MGMT and breast carcinoma: MS-HRM analysis was carried out to determine the methylation status of CCND2, DAPK1, GSTP1, HIN-1, MGMT and RASSF1A promoters in tumor tissues and histologically normal-appearing tumor-adjacent and tumor-distant tissues of 17 breast cancer patients.